CLINICAL_TRIALS ClinicalTrials.gov record update

Application of NY-ESO-1-specific TCR Affinity Enhancing Specific T Cell Therapy (TAEST16001) in Solid Tumors Except Non Small Cell Lung Cancer,Including Liver Cancer,Gastric Cancer,Esophageal Cancer and so on.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03159585
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:26.731226+00:00
Published At: 2020-01-22T00:00:00+00:00
Record Updated At: 2020-01-22
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Liver Cancer Stage IV", "Gastric Cancer Stage IV", "Esophageal Cancer, Stage IV", "Bone and Soft Tissue Tumors", "Breast Cancer Stage IV", "Bladder Carcinoma Stage IV", "Prostate Carcinoma Stage IV", "Thyroid Cancer Stage IV", "Ovarian Cancer Stage IV", "Solid Tumor"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-01-22"
protocolSection.identificationModule.nctId: "NCT03159585"
protocolSection.identificationModule.officialTitle: "Application of NY-ESO-1-specific TCR Affinity Enhancing Specific T Cell Therapy (TAEST16001) in Solid Tumors Except Non Small Cell Lung Cancer,Including Liver Cancer,Gastric Cancer,Esophageal Cancer and so on."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.